Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C.

Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C.

Show other versions (1)

Bibliographic Details
Main Authors:	Carmen Elena Gómez, Beatriz Perdiguero, Victoria Jiménez, Abdelali Filali-Mouhim, Khader Ghneim, Elias K. Haddad, Esther D. Quakkerlaar, Julie Delaloye, Alexandre Harari, Thierry Roger, Thomas Dunhen, Rafick P. Sékaly, Cornelis J. M. Melief, Thierry Calandra, Federica Sallusto, Antonio Lanzavecchia, Ralf Wagner, Giuseppe Pantaleo, Mariano Esteban
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3359381

Similar Items

Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C.
by: Carmen Elena Gómez, et al.
Published: (2012-01-01)

Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.
by: Carmen Elena Gómez, et al.
Published: (2012-01-01)

Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C
by: Gómez C, et al.
Published: (2012-09-01)

Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome.
by: Julie Delaloye, et al.
Published: (2009-06-01)

Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-C.
by: Beatriz Perdiguero, et al.
Published: (2013-01-01)

Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors.
by: Esther D Quakkelaar, et al.
Published: (2011-02-01)

A Novel MVA-Based HIV Vaccine Candidate (MVA-gp145-GPN) Co-Expressing Clade C Membrane-Bound Trimeric gp145 Env and Gag-Induced Virus-Like Particles (VLPs) Triggered Broad and Multifunctional HIV-1-Specific T Cell and Antibody Responses
by: Beatriz Perdiguero, et al.
Published: (2019-02-01)

A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses.
by: Juan García-Arriaza, et al.
Published: (2011-01-01)

Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C
Published: (2012-01-01)

Correction: Systems Analysis of MVA-C Induced Immune Response Reveals Its Significance as a Vaccine Candidate against HIV/AIDS of Clade C
Published: (2012-01-01)

A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology.
by: Jie Liu, et al.
Published: (2016-03-01)

V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques
by: Tiffany M. Styles, et al.
Published: (2022-07-01)

An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV.
by: Jennifer D Watkins, et al.
Published: (2011-03-01)

EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.
by: Bart, P, et al.
Published: (2008)

Global prevalence and molecular characteristics of three clades within hepatitis B virus subgenotype C2: Predominance of the C2(3) clade in South Korea
by: Dong Hyun Kim, et al.
Published: (2023-03-01)

Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein
by: Beatriz Perdiguero, et al.
Published: (2023-11-01)

Homology of HIV-1 Indian subtype C tat gene with other subtypes correlates with the induction of potent cross clade immune responses following immunization with HIV-1 Indian subtype C mutated and codon optimized tat DNA/MVA vaccine in mice
by: Seth Pradeep, et al.
Published: (2006-12-01)

Extended Viral Shedding of MERS-CoV Clade B Virus in Llamas Compared with African Clade C Strain
by: Jordi Rodon, et al.
Published: (2023-03-01)

An immunoregulatory and tissue-residency program modulated by c-MAF in human TH17 cells
by: Aschenbrenner, D, et al.
Published: (2018)

Polymorphisms in RYBP and AOAH genes are associated with chronic rhinosinusitis in a Chinese population: a replication study.
by: Yuan Zhang, et al.
Published: (2012-01-01)

Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting
by: Spearman P, et al.
Published: (2012-09-01)

Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV
by: María Q. Marín, et al.
Published: (2020-08-01)

MvaT binds to the PexsC promoter to repress the type III secretion system in Pseudomonas aeruginosa
by: Liwen Yin, et al.
Published: (2023-11-01)

Schistosoma mansoni infection promotes SHIV clade C replication in rhesus macaques
by: Chenine, A, et al.
Published: (2005)

Insights into the Activity of Second-Generation Maturation Inhibitors against HIV Clade C
by: Dibya Ghimire, et al.
Published: (2020-06-01)

HIV-1 reservoir evolution in infants infected with clade C from Mozambique
by: Catherine K. Koofhethile, et al.
Published: (2023-02-01)

Immunogenicity of the outer domain of a HIV-1 clade C gp120
by: Xu Xiaodong, et al.
Published: (2007-05-01)

Induction of Broad and Polyfunctional HIV-1-Specific T Cell Responses by the Multiepitopic Protein TMEP-B Vectored by MVA Virus
by: Beatriz Perdiguero, et al.
Published: (2019-06-01)

Phylogenetics of <it>Cucumis </it>(Cucurbitaceae): Cucumber <it/>(<it>C. sativus</it>) belongs in an Asian/Australian clade far from melon (<it>C. melo</it>)
by: Schaefer Hanno, et al.
Published: (2007-04-01)

Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein.
by: Juliana Falivene, et al.
Published: (2012-01-01)

Low Genetic Polymorphism in the Immunogenic Sequences of <i>Rhipicephalus microplus</i> Clade C
by: Ismail Zeb, et al.
Published: (2022-11-01)

Comparative immunogenicity of HIV-1 clade C envelope proteins for prime/boost studies.
by: Douglas H Smith, et al.
Published: (2010-08-01)

High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure
by: Irene T. Schrijver, et al.
Published: (2022-02-01)

Pulmonary aspergillosis: diagnosis and treatment
by: Frederic Lamoth, et al.
Published: (2022-11-01)

DNA/MVA Vaccines for HIV/AIDS
by: Smita S. Iyer, et al.
Published: (2014-02-01)

CD8 T-cell-mediated control of the C clade HIV epidemic in subSaharan Africa
by: Goulder, P
Published: (2007)

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection.
by: Kshitij Wagh, et al.
Published: (2016-03-01)

Rapid ART in blood donors with acute and recent HIV clade C infection in South Africa
by: E. Murphy, et al.
Published: (2019-12-01)

Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection.
by: Samir K Lakhashe, et al.
Published: (2011-01-01)

An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses
by: Michela Falqui, et al.
Published: (2023-05-01)